|
|
Enron Mail |
_________________________________________________________________
B R E A K F A S T W I T H T H E F O O L Wednesday, November 8, 2000 benjamin.rogers@enron.com _________________________________________________________________ REGISTER TO BECOME A FOOL -- GET FREE STUFF! http://www.fool.com/m.asp?i=185957 _________________________________________________________________ Sponsored By: Credit Suisse First Boston CSFB and DLJ are now one. #1 in M&A deals. #1 in IPO volume. #1 in high-yield debt underwriting. The best part? That"s just the beginning. http://www.lnksrv.com/m.asp?i=185958 "Words are the most powerful drug used by mankind." -- Rudyard Kipling HUMAN GENOME'S Q3 Biotech company Human Genome Sciences announced a cash-rich Q3 yesterday. By LouAnn Lofton Rule Breaking biotechnology company Human Genome Sciences (Nasdaq: HGSI) reported third-quarter (ended September 30) earnings yesterday after the market's close. Revenues climbed for the drug development company, while losses widened. http://www.fool.com/m.asp?i=185959 Human Genome's third-quarter revenues increased to $8.1 million, compared to $7.4 million in last year's third quarter. Included in this amount is a licensing fee the company received from MedImmune (Nadaq: MEDI), related to a SmithKline Beecham (NYSE: SBH) vaccine development deal. The company lost $147 million in the quarter, including a onetime write-off related to the $134.1 million acquisition of Principia Pharmaceutical. Excluding this charge, Human Genome lost $13 million, or $0.12 a share. In the year-ago period, it lost $9.7 million, or $0.11 per share. Analysts as polled by First Call/Thompson Financial had expected Human Genome to lose $0.13 a share, excluding charges, so the company beat that by a penny. Human Genome Sciences had $849.5 million in cash and short-term investments as of the close of the quarter. This compares to the $466.2 million it had in cash and short-term investments at the end of December 1999. After the end of the third quarter, the company sold more stock to the public and raised an additional $950 million in cash. Counting that amount, Human Genome's current amount of cash and short-term investments is about $1.8 billion. The company now has about 124.8 million shares of outstanding common stock, compared to 112.1 million at the close of the third quarter. William A. Haseltine, Human Genome's chairman and chief executive officer, said in a statement, "We are pleased that our recent efforts have brought several HGS drugs closer to the patients who need them. At the same time, we focused on enabling scientists at HGS and our partners to discover and develop additional drugs that may aid more patients to lead healthier, more active lives." _________________________________________________________________ NEWS TO GO Online auction house eBay (Nasdaq: EBAY) is cutting some of its offline workers. About 15% of the employees at the eBay-owned Butterfields fine-art auction company will be losing their jobs. That equals about 32 people. eBay cut 13 jobs at the Chicago Butterfields office back in July. eBay spokesman Kevin Pursglove said, "The management team at Butterfields came to the conclusion that they will continue to move the business to the online area." Good-bye, MotherNature.com (Nasdaq: MTHR). Just after we lost Pets.com (Nasdaq: IPET) and that annoyingly cute little sock puppet, MotherNature.com announced that it, too, is shutting its doors. MotherNature.com is the second venture backed by CMGI (Nasdaq: CMGI) to go belly-up this week. The other, online furniture retailer Furniture.com, announced that it's closing on Monday. MotherNature.com spent time looking for a buyer for its online vitamins and health products business, but could find no takers. The company's board of directors approved a plan to liquidate and dissolve the company on Tuesday. Preppy-chic designer and retailer Polo Ralph Lauren (NYSE: RL) announced second-quarter results this morning. The company's sales grew by 8% to $586.2 million, compared to $543.9 million last year. Net income, before restructuring and other special charges, was $48.8 million, versus $55.3 million in the year-ago period. Earnings per diluted share on this basis were $0.50, down from last year's $0.56. The company said the reduction in net income and earnings per share was expected because of a delay in recognizing some European sales results, as well as a shift with the timing of some of its shipments. AOL Latin America (Nasdaq: AOLA) reported first-quarter results yesterday. The Internet services provider, which is a joint venture between America Online (NYSE: AOL) and the Cisneros Group of Companies, lost $0.36 a share, or $98.1 million. Analysts had expected a loss of $0.37 a share. Revenues in the quarter were $4.6 million. AOL Latin America said it added 191,000 users in the quarter, bringing its total number of members to 314,000. Check out all of yesterday's market Foolishness with a single click. http://www.fool.com/m.asp?i=185960 _________________________________________________________________ EDITORS' PICK The Fool editorial staff selects seven must-read investing classics. How many have you read? http://www.fool.com/m.asp?i=185961 _______________________________________________________________ -News & Commentary http://www.fool.com/m.asp?i=185962 -Fool Community http://www.fool.com/m.asp?i=185963 -Post of the Day http://www.fool.com/m.asp?i=185964 -Latest Fribble http://www.fool.com/m.asp?i=185965 -Latest Market Numbers http://www.fool.com/m.asp?i=185966 ____________________________________________________________ My Portfolio: http://www.fool.com/m.asp?i=185967 My Discussion Boards: http://www.fool.com/m.asp?i=185968 My Fool: http://www.fool.com/m.asp?i=185969 Fool.com Home: http://www.fool.com/m.asp?i=185970 My E-Mail Settings: http://www.fool.com/m.asp?i=185971 Sponsored By: Credit Suisse First Boston CSFB and DLJ are now one. #1 in M&A deals. #1 in IPO volume. #1 in high-yield debt underwriting. The best part? That"s just the beginning. http://www.lnksrv.com/m.asp?i=185972 FREE BOOK, JUST FOR FOOLS! Investor's Business Daily will send you a free copy of 24 Essential Lessons for Investment Success when you sign up for a free trial subscription of their newspaper. http://www.lnksrv.com/m.asp?i=185973 NEW! EMC THIRD-QUARTER UPDATE The company continues to see incredible growth. Find out what lies ahead with Motley Fool Research. http://www.lnksrv.com/m.asp?i=185974 FOOL DIRECT E-MAIL SERVICES Need to change your address or unsubscribe? You can also temporarily suspend mail delivery. Click here: http://www.fool.com/community/freemail/freemaillogin.asp?email=benjamin.rogers @enron.com< Have ideas about how we can improve the Fool Direct or new e-mail products you'd like to see? Try our discussion board: http://www.fool.com/m.asp?i=185975 ____________________________________________________ © Copyright 2000, The Motley Fool. All rights reserved. This material is for personal use only. Republication and redissemination, including posting to news groups, is expressly prohibited without the prior written consent of The Motley Fool. . MsgId: msg-14441-2000-11-08_9-00-48-3244856_2_Plain_MessageAddress.msg-09:05:03(11-08 -2000) X-Version: mailer-sender-master,v 1.84 X-Version: mailer-sender-daemon,v 1.84 Message-Recipient: benjamin.rogers@enron.com
|